Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

More daily smokers with tuberculosis receiving a mobile health intervention achieved self-reported and biochemically verified ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

CureTB referrals showed higher TB treatment completion when patients were linked to care quickly after relocation.

Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.